ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE

L E G N A R O (PD)

D E L I B E R A Z I O N E

D E L D I R E T T O R E G E N E R A L E

N. 202 del 04/07/2022

OGGETTO: Approvazione dello schema di ``Service Agreement`` tra l`Istituto Zooprofilattico Sperimentale delle Venezie e AquaBioTech Limited.

Atto sottoscritto digitalmente ai sensi del D.Lgs. 82/2005 s.m.i. e norme collegate e sostituisce il documento cartaceo e la firma autografa

ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE

L E G N A R O (PD)

DELIBERAZIONE DEL DIRETTORE GENERALE

OGGETTO: Approvazione dello schema di ``Service Agreement`` tra l`Istituto Zooprofilattico Sperimentale delle Venezie e AquaBioTech Limited.

Si sottopone al Direttore generale la seguente relazione del Responsabile della S.S. Affari Generali, Anticorruzione e Trasparenza.

Si premette che:

- l’articolo 1, comma 6, del Decreto Legislativo n. 270/1993, confermato all’art. 9, comma 2, del Decreto Legislativo n. 106/2012, consente agli Istituti Zooprofilattici Sperimentali di “[…] stipulare convenzioni o contratti di consulenza per la fornitura di servizi e per l’erogazione di prestazioni ad enti, associazioni, organizzazioni pubbliche e private, sulla base di disposizioni regionali, fatte salve le competenze delle unità sanitarie locali”;

- l’articolo 5, comma 1 – rubricato “Attività verso terzi” – dell’Accordo per la gestione dell’Istituto Zooprofilattico Sperimentale delle Venezie approvato dalla Regione del Veneto, dalla Regione Autonoma Friuli Venezia Giulia e dalle Province Autonome di Trento e Bolzano, rispettivamente, con Leggi n. 5/2015, n. 9/2015, n. 5/2015 e n. 5/2015, prevede, del pari, che “Fermo restando l’assolvimento dei propri compiti istituzionali, l'istituto può fornire prestazioni a terzi a titolo oneroso, stipulando convenzioni o contratti di consulenza per la fornitura di servizi e per l'erogazione di prestazioni a enti, associazioni, organizzazioni pubbliche e private sulla base di disposizioni regionali, fatte salve le competenze delle aziende unità sanitarie locali (…)”;

- con riferimento a tali disposizioni, l’art. 5, comma 1, dello Statuto dell’Istituto – adottato con DCA n. 12 del 24.05.2021 e approvato con DGRV n. 1308 del 28.09.2021 – prevede che l’Istituto “[…] può fornire prestazioni a terzi a titolo oneroso, stipulando convenzioni o contratti di consulenza per la fornitura di servizi e per l'erogazione di prestazioni a soggetti privati, ad imprese, enti, associazioni, organizzazioni pubbliche e

Atto sottoscritto digitalmente ai sensi del d.lgs. 82/2005 s.m.i. e norme collegate e sostituisce il documento cartaceo e la firma autografa

Pagina 1 di 5

X.X.X.Xx – Deliberazione del DIRETTORE GENERALE

private sulla base di disposizioni degli enti cogerenti […]”; il comma 2 del citato art. 5, stabilisce che “Nelle more delle disposizioni di cui al punto precedente, l’Istituto continua ad applicare le modalità in atto”;

- l’art. 6, comma 2, lett. e) del D. Lgs. n. 270/1993, confermato all’art. 3, comma 2, lett. e) della Legge della Regione del Veneto n. 5 del 18.03.2015, prevede che il finanziamento degli Istituti Zooprofilattici Sperimentali sia, inoltre, assicurato “dagli introiti per la fornitura di servizi e per l’erogazione di prestazioni a pagamento”;

- i vigenti documenti di programmazione di IZSVe prevedono – tra gli indirizzi approvati – la promozione e l’incentivazione di attività progettuali finanziate da soggetti terzi ad integrazione del finanziamento istituzionale.

Con DDG n. 317 del 26.6.2013, è stato approvato il nuovo “Regolamento per la prestazione di attività e servizi aggiuntivi in favore di soggetti privati tramite la stipula di contratti e convenzioni” e con nota prot. n. 10134/2013 è stata diffusa la relativa circolare interpretativa a firma del Direttore generale.

Quest’ultima prevede che le attività non-istituzionali cd. semplici, così come enucleate e definite all’interno della stessa circolare, deroghino dall’ambito di applicazione del citato Regolamento e, pertanto, dalla procedura di approvazione del contratto ivi stabilita.

Con nota del 20.04.2022, acquisita al ns. prot. n. 3789 del 22.04.2022, la società AquaBioTech Limited con sede in Malta, ha richiesto all’IZSVe di addivenire alla stipula di un contratto avente ad oggetto la fornitura di ceppi virali di origine ittica.

In conformità alle soprarichiamate disposizioni, la Dott.ssa Xxxx Xxxxxx, dirigente veterinario presso la “SCS6 – Virologia speciale e sperimentazione”, al fine di dare seguito alla richiesta, ha inserito, in qualità di referente scientifico, la richiesta intranet n. 180019/2022, allegando, tra gli altri documenti, la propria dichiarazione per la stipula del contratto con la suddetta società, come previsto dalla citata circolare interpretativa.

Tramite la suddetta dichiarazione, la Dott.ssa Xxxx Xxxxxx ha attestato che le attività richieste da AquaBioTech Limited rientrano nelle attività non-istituzionali cd. semplici come definite nella circolare interpretativa prot. n. 10134/2013, alle quali, pertanto, non si applica la procedura prevista dal Regolamento approvato con DDG n. 317/2013; tale documento, unitamente al quadro economico, che sinteticamente evidenzia i costi a carico dell’Istituto per le attività da eseguire, sono conservati agli atti della scrivente Struttura.

Al fine di formalizzare il rapporto e regolarne gli aspetti giuridici ed economici, le parti hanno concordato, per le vie brevi, lo schema di “Service Agreement”, documento che si allega al presente provvedimento quale parte integrante e sostanziale (allegato n. 1), unitamente al relativo “Annex A”.

Ai sensi del contratto in parola, la società AquaBioTech Limited si impegna a corrispondere all’IZSVe l’importo di € 6.000,00, IVA esclusa, oltre le spese di spedizione, subordinatamente alla presentazione di regolare fattura, secondo le modalità previste all’art. 2.

Tutto ciò premesso, sulla base degli elementi riportati dal referente dell’istruttoria, si propone al Direttore generale quanto segue:

Atto sottoscritto digitalmente ai sensi del d.lgs. 82/2005 s.m.i. e norme collegate e sostituisce il documento cartaceo e la firma autografa

Pagina 2 di 5

X.X.X.Xx – Deliberazione del DIRETTORE GENERALE

1. di approvare lo schema di “Service Agreement” tra l’Istituto Zooprofilattico Sperimentale delle Venezie, rappresentato dal Direttore Generale e legale rappresentante pro tempore, Dott.ssa Xxxxxxx Xxxxx, e la società AquaBioTech Limited, rappresentata dal Xxxx. Xxxxxx Xxxxxxx, documento che si allega al presente provvedimento quale parte integrante e sostanziale (allegato n. 1), unitamente al relativo “Annex A”;

2. di procedere, per l’effetto, alla sottoscrizione del contratto di cui al punto che precede, ai sensi degli artt. 15 e 16 del vigente Accordo interregionale sulla gestione dell’Istituto Zooprofilattico Sperimentale delle Venezie;

3. di prendere atto della dichiarazione con la quale la Dott.ssa Xxxx Xxxxxx, dirigente veterinario presso la “SCS6 – Virologia speciale e sperimentazione”, in qualità di referente scientifico, ha attestato che le attività richieste dalla società AquaBioTech Limited rientrano nelle cd. “attività non-istituzionali semplici” come definite dalla circolare prot. n. 10134/2013, nonché del quadro economico che evidenzia sinteticamente i costi a carico dell’Istituto per le attività da eseguire, documenti allegati alla richiesta intranet n. 180019/2022 e conservati agli atti della scrivente Struttura;

4. di prendere atto, altresì, che la società AquaBioTech Limited, con la sottoscrizione del predetto contratto, corrisponderà all’Istituto per l’esecuzione delle prestazioni dedotte in contratto, un importo di € 6.000,00, IVA esclusa, oltre le spese di spedizione, subordinatamente alla presentazione di regolare fattura, secondo le modalità previste all’art.2;

5. di rilevare il ricavo derivante dal presente provvedimento al sottoconto 620011003 “Ricavi per prestazioni sanitarie erogate a soggetti privati – Altre convenzioni” attribuito pro quota a ciascun esercizio finanziario secondo il criterio di competenza economica.

IL DIRETTORE GENERALE

ESAMINATA la proposta di deliberazione del Responsabile della S.S. Affari Generali, Anticorruzione e Trasparenza che attesta la regolarità della stessa in ordine ai contenuti sostanziali, formali e di legittimità dell’atto, attestazione allegata al presente provvedimento.

VISTO il decreto del Presidente della Giunta regionale del Veneto n. 102 del 22 settembre 2020 con il quale è stata nominata la dott.ssa Xxxxxxx Xxxxx quale Direttore generale dell’Istituto Zooprofilattico Sperimentale delle Venezie.

VISTA la delibera del Direttore generale n. 372 del 14 ottobre 2020 con la quale la dott.ssa Xxxxx Xxxxxxx è stata nominata Direttore sanitario dell’Istituto.

VISTA la delibera del Direttore generale n. 101 del 10 marzo 2021 con la quale il xxxx.

Xxxxxxx Xxxxxx è stato nominato Direttore amministrativo dell’Istituto.

ACQUISITO il parere favorevole del Direttore amministrativo e del Direttore sanitario per quanto di competenza, espresso ai sensi dell’art. 15 dello Statuto dell’Istituto, adottato con delibera del CdA n. 12 del 24 maggio 2021 e approvato con delibera della Giunta regionale del Veneto n. 1308 del 28 settembre 2021.

Atto sottoscritto digitalmente ai sensi del d.lgs. 82/2005 s.m.i. e norme collegate e sostituisce il documento cartaceo e la firma autografa

Pagina 3 di 5

X.X.X.Xx – Deliberazione del DIRETTORE GENERALE

VISTO l’Accordo per la gestione dell’Istituto Zooprofilattico Sperimentale delle Venezie tra la Regione del Veneto, la Regione Autonoma Friuli Venezia Giulia e le Province Autonome di Trento e Bolzano, approvato dai suddetti Enti, rispettivamente, con leggi n. 5/2015, n. 9/2015, n. 5/2015 e n. 5/2015.

D E L I B E R A

Il presente provvedimento non è soggetto al controllo previsto dall’Accordo per la gestione dell’Istituto Zooprofilattico Sperimentale delle Venezie approvato dagli Enti cogerenti con le leggi regionali e provinciali citate nelle premesse.

IL DIRETTORE GENERALE

dott.ssa Xxxxxxx Xxxxx

Sul presente atto deliberativo ha espresso parere favorevole

Il Direttore amministrativo Il Direttore sanitario

xxxx. Xxxxxxx Xxxxxx dott.ssa Xxxxx Xxxxxxx

Atto sottoscritto digitalmente ai sensi del d.lgs. 82/2005 s.m.i. e norme collegate e sostituisce il documento cartaceo e la firma autografa

Pagina 4 di 5

X.X.X.Xx – Deliberazione del DIRETTORE GENERALE

ATTESTAZIONI ALLEGATE ALLA DELIBERAZIONE DEL DIRETTORE GENERALE

Il Responsabile della Struttura proponente attesta la regolarità della proposta di deliberazione, presentata per l’adozione, in ordine ai contenuti sostanziali, formali e di legittimità dell’atto e che la stessa:

Comporta spesa 🞏 su Finanziamento istituzionale 🞏

Finanziamento vincolato 🞏

Altri finanziamenti 🞏

Non comporta spesa ⌧

ATTESTAZIONE DI COPERTURA ECONOMICA DELLA SPESA

Il Responsabile del Budget attesta l’avvenuto controllo sulla disponibilità di budget

Evidenziato infine che il responsabile della Struttura proponente, con la sottoscrizione della proposta di cui al presente atto, dichiara, sotto la propria responsabilità ed ai sensi e agli effetti degli artt. 47 e 76 del dPR 28 dicembre 2000, n. 445, che, in relazione alla presente procedura, non si trova in condizioni di incompatibilità di cui all’art. 35 bis del d.lgs. n. 165/2001, né sussistono conflitti di interesse di cui all’art. 6 bis della legge n. 241/1990 e agli artt. 6, 7 e 14 del dPR n. 62/2013.

dott.ssa Xxxxxx Xxxxxxxx

Atto sottoscritto digitalmente ai sensi del d.lgs. 82/2005 s.m.i. e norme collegate e sostituisce il documento cartaceo e la firma autografa

Pagina 5 di 5

ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE

Viale dell’Università 10 – 00000 XXXXXXX (XX)

DELIBERAZIONE DEL DIRETTORE GENERALE N. 202 del 04/07/2022‌

OGGETTO: Approvazione dello schema di ``Service Agreement`` tra l`Istituto Zooprofilattico Sperimentale delle Venezie e AquaBioTech Limited.

Pubblicata dal 04/07/2022 al 19/07/2022 Atto immediatamente esecutivo

Il Responsabile della Pubblicazione Xxxxxxxx Xxxxx

Elenco firmatari

Questo documento è stato firmato da:

Dott.ssa Xxxxxx Xxxxxxxx - Servizio Affari generali, anticorruzione e trasparenza Xxxx. Xxxxxxx Xxxxxx - Direzione Amministrativa

Dott.ssa Gioia Capelli - Direzione Sanitaria Dott.ssa Xxxxxxx Xxxxx - Direzione Generale Xxxxxxxx Xxxxx - Gestione Atti

SERVICE AGREEMENT

BY AND BETWEEN

Istituto Zooprofilattico Sperimentale delle Venezie, an Italian governmental institution, with offices at Xxxxx xxxx’Xxxxxxxxxx 00, 00000 Xxxxxxx (XX), Xxxxx, fiscal code and VAT n. 00206200289, PEC: xxxxxxxxxx@xxxxxxxxx.xx, represented by Dr. Xxxxxxx Xxxxx, Acting Director General and Legal Representative, fiscal personal code n. XXXXXX00X00X000X

(hereinafter referred to as “IZSVe” or “Supplier”)

and

AquaBioTech Ltd a company organized under the laws of Malta, having its registered office at ‘Central Complex’, Xxxxxx Xxx., Xxxxx XXX0000, Xxxxx, VAT No. 15170707, represented by Dr.

Xxxxxx Xxxxxxx, CRO Director

(hereinafter referred to as the “ Company” or “Customer”

and severally as “Party” and jointly as “ Parties”)

WHEREAS, IZSVe is involved in providing diagnoses and research on infectious livestock diseases and zoonosis, quality control of foods of animal origin for human consumption, control of animal feed, epidemiologic surveillance and monitoring, planning of animal health programs, training of veterinary service personnel and production of biopharmaceuticals;

WHEREAS, the Company requires IZSVe to perform certain services regarding producing and selling of fish viruses that will be used for the purpose of carrying out research into the efficacy of vaccines and other health products in species of fish currently being cultured by aquaculture, performed at Aquabiotech in Malta;

WHEREAS, IZSVe is interested in performing the services requested by the Company in compliance with the rules in force regarding the management of the IZSVe;

NOW, THEREFORE,

in consideration of the covenants and obligations hereinafter set forth, the Parties hereto, individually and by their respective agents and representatives, hereby agree as follows:

1. SERVICES

The Company requests and IZSVe shall perform certain service regarding producing and selling of fish viruses, namely IPNV and IHNV (hereinafter referred to as “Services”) on the terms and conditions of this Agreement and in accordance with the attached Annex A (“Services”), that is an integral and essential part of it.

The Products purchased by AquaBiotech from IZSVE will be delivered from IZSVE to AquaBiotech warehousing and production facilities in Malta using a delivery schedule to be mutually agreed by both Parties. AquaBiotech shall bear all the delivery cost and other costs associated with transport.

Following receipt of the Products in fit for purpose condition at AquaBiotech facilities, all liabilities relating to Products will be the responsibility of AquaBiotech.

2. CONSIDERATION

The Company shall pay to IZSVe for all Services rendered pursuant to this Agreement a lump sum of Euro 6000,00 (in words six thousands) (taxes and pension fund included but VAT excluded) against presentation of regular invoice.

Additional fish viruses not included in Annex A, may be required to IZSVE by AquaBiotech, and the transfer price will be agreed between the Parties in writing.

Shipping costs are not included.

IZSVe will ship the samples identified above in compliance with the applicable law and rules. Shipping costs via dedicated courier company will be charged on AquaBiotech.

Invoices may be sent by regular mail or e-mail.

The payment shall be made by bank transfer using the following bank details: Beneficiary bank – Intesa San Paolo

Bank account – IBAN XX00X0000000000000000000000

BIC or SWIFT code – XXXXXXXX.

The Company undertakes to make all payments due under this Agreement within 30 days after the receipt of invoice by IZSVe.

All payments by the Company shall constitute admission by the Company as to the performance by IZSVe of its obligations under this Agreement.

In case the payment’s delay exceeds one hundred and eighty (180) days, IZSVe may terminate this Agreement pursuant to art. 6 of this Agreement, without prejudice to its right to claim for further damages, if any.

The Parties agree that this Agreement is subject to VAT according to Italian law (D.P.R. n. 633/1972 and its amendments) that is conform to EU single market rules. The registration fee is due just in the event of judicial or administrative use, as set forth in Italian law (D.P.R. n. 131/1986) and costs and expenses will be borne by the requesting Party. The Parties will contribute in equal measure to the other tax duties related to this agreement, stamp duty included.

3. TERM

This Agreement shall be effective upon the execution and shall remain in force until the completion of the Services by IZSVe and payment by the Company of the corresponding compensation.

4. WARRANTIES AND LIABILITY

IZSVe represents that it has the requisite expertise, ability and legal right to perform the obligations under this Agreement and that it will perform the obligations under this Agreement in an efficient and ethical manner and using its best efforts. IZSVe will abide by all laws, rules and regulations that apply to the performance of the obligations under this Agreement, as well as the policies of the Company, where required and provided by the Company.

The Company acknowledges that the Strains are supplied with no warranties, express or implied, including but not limited to any warranty of fitness for a particular purpose. Specifically, the Company acknowledges that detailed information on the virus phenotype for these strains, including their pathogenicity in experimental trials, are available at the IZSVe and provided, if requested.

IZSVe and its directors, officers, employees assume no liability and make no representation in connection with the Strains or derivatives or information or their use by the Company or its investigators.

However IZSVe represents and warrants the Company that its execution will not result in a breach of any obligation to any third party or infringe or otherwise violate any third party’s rights.

In no event shall IZSVe be liable to the Company for any use of the Strains by the Company

If the Strains are not viable or are not delivered in sufficient amounts, the Company shall send a written notification to IZSVe within thirty (30) days after the receipt of the Strains (or in case non- delivery of Strains, within thirty (30) days of the agreed date of shipment). In these cases, IZSVe shall replace the Strains only. This warranty is valid if the Recipient ensures that the Strains have been stored or processed as indicated in the documents that will accompany the Strains.

The Company assumes all liability for any and all third party damages and claims arising out of or relating the use of Strains, including the receipt, use, handling, storage, conservation of the Strains. The Company hereby agrees to defend, indemnify and hold harmless IZSVe and its employees from any loss, claim, damage expenses or liability in connection with the Strains that occurred after the moment the Strains left the laboratory of IZSVe and are in the Company possession, except if such loss, claim or damage is due to natural disasters or any causes beyond its reasonable control including, without limitation, any act of God, any civil commotion or strike.

5. TREATMENT OF CONFIDENTIAL INFORMATION

To “Confidential Information” means all information disclosed by one Party to the other Party, in writing, orally or any other form, during the performance of this Agreement, and all samples and materials provided by the Company which are not in the public domain or such information thereafter becomes a part of public domain. Confidential Information includes the Training Material.

During the term of this Agreement and for a period of 60 months following its expiration, IZSVe and the Company agree to keep confidential all Confidential Information disclosed by and received and to maintain appropriate safeguards with respect to the Confidential Information. Under no circumstances neither Party shall disclose the Confidential Information to any person other than to those individuals and entities on a need-to-know basis. The Parties stipulate that, as between them, the foregoing matters are important, material and confidential, and gravely affect the effective and successful conduct of the business of the Company and its goodwill, and that any breach of this covenant is a material breach of this Agreement. In the event that IZSVe is requested or required by law or legal process to disclose any of the Confidential Information, IZSVe shall provide the Company with prompt written notice before making any disclosure. In addition, Confidential Information may be disclosed to the extent required in the course of inspections or inquiries by EU Federal or State regulatory agencies to whose jurisdiction IZSVe and/or the Company is/are subject to and that has/have the legal right to inspect documents containing the Confidential Information. IZSVe shall promptly advise the Company upon such disclosure and vice versa.

During the term of this Agreement and for a period of 60 months following its expiration, IZSVe agrees to not use, disclose, disseminate, communicate or reveal any of the Confidential Information or any part thereof, to any person or entity for any reason or purpose whatsoever, unless otherwise agreed.

6. USE OF THE MATERIAL AND INTELLECTUAL PROPERTY

Subject to the terms and conditions herein, the Company expressly agrees that no other use detailed above are allowed, unless IZSVe expressly agrees to.

The Company agrees that the Material:

a) will not be used for Commercial Purposes; any commercial use of the Material is strictly forbidden. The Company undertakes not to sell, lend, supply, disclose, transfer, give or distribute the Material to any third party;

b) will not be used in human subjects, in clinical trials, or for diagnostic purposes involving human subjects without the Provider's prior written consent;

c) will be used only at the Recipient organization and only in the Researcher's laboratories under the direction of the Researcher or others working under his or her direct supervision;

d) will not be further transferred without the Provider's prior written consent.

The Company will refer any request for the Material from anyone other than those persons working under the Researcher's direct supervision to the Provider's Scientist.

Upon request, the Company will provide to IZSVe with a summary of the Research Activities obtained with the Material.

The Company will use the Material in compliance with all Malta laws and governmental regulations guidelines recommendations issued by national and international body applicable to the Material and Modifications.

The strain shall not be incorporated into any service or product for sale, or used for the commercial provision.

The Company is free to release scientific publications concerning the outcomes of the scientific research carried out with the Strains. Every publication referred to the Strains or Derivatives shall acknowledge the source of the material, giving the due reference to IZSVe.

All intellectual property rights resulting from the development of products for which the Comapny or any Company affiliate has used the Strains as research materials shall be the sole property of the Company and the Company shall have the right at its own discretion to apply for patents in its own name and at its own expense.

IZSVe and the Recipient shall be co-owner of possible modifications of the Strains (i.e. the Derivatives). In that case the Parties shall negotiate with an appropriate written Agreement the means of commercial exploitation, patenting, and the regulation of the respective aspects.

Neither Party shall use the name or the logo of the other Party, of its Principal Investigator or its employees in any publicity, new release, publication or advertising without the express prior written approval of the Party. The Parties acknowledge and agree that all intellectual property rights related to the logo will remain exclusive property of the owning Party; particularly, with no limitation, the usage of the logo of a Party by the other Party will not transfer to the using Party any rights or titles related to the logo.

7. TERMINATION CLAUSE

Without prejudice to the provisions set forth in this Agreement, either Party may terminate this Agreement for cause upon 30 (thirty) days written notice, if any of the following events occur:

i)any material breach of the terms of this Agreement. Any violation of the contractual obligations may be considered a material breach if such violation is repeated notwithstanding a request by the other Party to fulfill the contractual obligations;

ii) if either Party to this Agreement ceases to function as a going concern, or a receiver for it is appointed or applied for, or a petition under any bankruptcy, insolvency or similar reorganization statute pursuant to the applicable law is filed by or against it, or it makes an assignment for the benefit of creditors which is not dismissed or withdrawn within 60 (sixty) days of the institution thereof, then the other Party shall have the right to terminate this Agreement.

The Party that wishes to terminate the Agreement under this clause shall communicate its intention to the other Party. The termination shall be effective as 30 days from the moment of the receipt of the termination notice. The fulfillment of the obligations by the breaching Party until the receipt of the termination notice shall not jeopardize the right of the other Party to claim for damages.

In the event of termination of this Agreement, the effect of termination shall not prejudice the obligations already performed by the Parties and shall not jeopardize the rights acquired by each Party

until the Termination Date. The Samples received by IZSVe prior to the receipt of the termination notice, which have not been used, shall be returned to the Company at costs and expenses of the Party that exercised the termination right. In the event of such a termination, IZSVe will communicate to the Company the results generated until the Termination Date.

In case of earlier termination, the Company will pay to IZSVe a sum, inferior to the amount initially agreed settled, but to be agreed in writing by the Parties in proportion to the activities actually performed by IZSVe until the Termination Date.

Termination of this Agreement for any reason shall be without prejudice to the rights which expressly survive the termination in accordance with the terms of this Agreement and applicable laws, including without limitation, the rights and obligations of the Parties regarding to Intellectual Property Rights, Publicity and Publication, samples and materials.

8. WITHDRAWAL

Each Party has the right to withdraw from this Agreement at any time, by giving twenty (20) days notice in writing, as forth in art.11. The termination will not affect the obligations already performed by the Parties or whose performance is in progress at the time of termination.

9. FORCE MAJEURE

IZSVe shall not be liable for failure of or delay in performing obligations set forth in this Agreement, or for having incorrectly performed them, and shall not be deemed in breach of its obligations, if such failure, delay or incorrect performance is due to natural disasters or any causes beyond its reasonable control including, without limitation, any act of God, any civil commotion or strike. In the event of such force majeure, the Party affected thereby shall promptly notify the other Party in writing. If the force majeure lasts more than 90 days, the Party shall have the right to terminate the Agreement; the notice of termination shall be made according to the following art. 11.

10. TREATMENT OF PERSONAL DATA

According to and in compliance with the General Data Protection Regulation UE 2016/679 (GDPR), the Parties acknowledge and agree to use, process and communicate to any third party the personal data contained herein, or acquired in any other form during the performance of this agreement, solely and exclusively in order to carry out the purposes set forth in the agreement itself or to accomplish the fulfillments connected to it. Each Party authorizes the process of its data solely and exclusively in order to manage the agreement according to the terms and conditions set forth in the said law.

11. GOVERNING LAW AND DISPUTE RESOLUTION

This Agreement shall be subject to, governed by and construed in accordance with the laws of Italy (without regard to the conflicts of law rules which might result in the application of the laws of any other jurisdiction). All disputes, controversies or differences which may arise between the Parties out of or in connection with this agreement, its interpretation or performance, shall be submitted to the exclusive jurisdiction of the Court of Padua, Italy.

12. MISCELLANEOUS

The delay or failure of either Party to enforce at any time or for any period of time any of the provisions of this agreement shall not be construed as a waiver of such provisions or of the right of the Party to thereafter seek their enforcement.

The Parties claim that all rights that allow the signing and performance of this agreement and that allow the other Party to perform the obligations set forth herein, belong to them. Each Party claims

that the signing and performance of this agreement and the rights set forth herein do not compromise any third party rights.

If one or more of the provisions of this Agreement should be or become invalid or impracticable, the validity of the remaining provisions shall not be effected. The Parties shall in good faith make any efforts to replace the invalid or impracticable provision by an effective provision which must closely approximate to the purpose of this Agreement.

IZSVe and the Company will act all times as independent contractors. Nothing contained herein shall be construed or applied so as to create the relationship of principal and agent or of employer and employee between IZSVe and the Company or any partnership or joint-venture. Neither Party shall make any commitment or incur any charge or expense in the name of the other Party.

This Agreement and the rights and duties set forth herein may not be assigned, transferred, delegated or sub-contracted by either Party without the written consent of the other Party.

For anything not expressly regulated by this contract, the parties will make exclusive reference to the legislation in force in the Italian legal system, in particular the laws of the Civil Code and the general conditions of contract available on the Institute's website (xxx.xxxxxxxxxx.xx) and subsequent amendments and / or additions.

This Agreement may be amended, modified, superseded or canceled, only by a written instrument executed by each Party’s duly authorized representatives.

All notices and communications related to this agreement shall be made by registered or certified letter, return receipt requested, telecopier or electronic transmission confirmed in writing by register letter and shall be addressed as follows (or to other address as may hereafter be designed by written notice):

If to IZSVe: Att. Xxxx Xxxxxx

Istituto Zooprofilattico Sperimentale delle Venezie Viale dell’Università 10

00000 - Xxxxxxx (XX) XXXXX

Fax 0039/000000000

e-mail xxxxxxx@xxxxxxxxxx.xx

If to the Company: Att. Dr. Xxxxxx Xxxxxxx AquaBioTech Ltd.

‘Central Complex’ Xxxxxx Xxx., Xxxxx XXX0000 Xxxxx.

13. NEGOTIATIONS

This Agreement has been freely negotiated between the Parties hereto and represent their willingness as duly and clearly shown in the content hereof and properly considered.

IN WITNESS WHEREOF, the Parties have caused this agreement to be executed by their duly authorized representatives.

This agreement is made at the date and place of the last signature.

IZSVe The Company

General Manager Legal representative

Dr. Xxxxxxx Xxxxx Dr. Xxxxxx Xxxxxxx

Date Date

Annex A

Summary of the characteristic of the viral strains:

Virus

Isolate/material (ID)

Year of isolation

Source of isolation

Minimum viral titre

Amount

Aquabirnavirus, Infectious pancreatic necrosis virus

IPNV/X.xxxxxx/I/ TN/76/Mar14

2014

Onchorynchus mykiss

108,00

TCID50/ml

10 mL

Novirhabdovirus, Salmonid novirhabdovirus

IHNV/O.mykiss/I/ TN/224/Mar18

2018

Onchorynchus mykiss

106,00

TCID50/ml

10mL

Document Metadata

Table of Contents

ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE

Document Metadata